Neurometrix Inc Share Price

NASDAQ: NURO

$4.58

+0.22

(+5.05%)

as on May 2, 2025 at 1:25 am IST

$₹

The stock has been delisted from the stock exchange on 29 Apr 2025

Neurometrix Inc Stock Performance

as on May 2, 2025 at 1:25 am IST

$4.58
Day's Price Range
$4.58
$4.58
52 Week's Low
52 Week's High
$3.22
52-Week Price Range
$4.73
$4.58
29.69%
Downside
3.28%
Upside

Neurometrix Inc share price movements today

Previous Close: $4.36
Open: $4.58
Volume: 200.0
Day's Low - High: $4.58 - $4.58
52 Week Low - High: $3.22 - $4.73

Neurometrix Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Neurometrix Inc Stock Fundamentals & Key Indicators

Check Neurometrix Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Neurometrix Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Neurometrix Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Neurometrix Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Neurometrix Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Neurometrix Inc. Average target price of $50

Neurometrix Inc Share Price Target

Get share price movements and forecasts by analysts on Neurometrix Inc.

What analysts predicted

90.84%UPSIDE

Target Price

$50

Current Price

$4.58

Analyzed by

7 Analysts

Target

$50.00

Neurometrix Inc target price $50, a slight upside of 90.84% compared to current price of $4.58. According to 7 analysts rating.

Neurometrix Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Total Revenue	1	1	1	1	1	1	1	0	0	0
Gross Profit	1	1	1	1	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-1	0	-1	-1	-1	-1	-3	-1	-1	-1
Net Profit Margin	-76.19%	-36.90%	-83.39%	-92.83%	-147.01%	-125.18%	-277.04%	-193.45%	-256.80%	-305.47%

Neurometrix Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	7	12	17	16	9	7	8	8	5	3
Gross Profit	3	4	6	7	2	5	5	5	3	1
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-9	-14	-12	0	-3	-2	-2	-4	-6	-7
Net Profit Margin	-125.86%	-123.99%	-75.23%	0.15%	-39.35%	-27.14%	-26.72%	-52.90%	-110.64%	-257.38%

Global Institutional Holdings in Neurometrix Inc

Funds	Holdings
Deltec Asset Management LLC	0.89%
Vanguard Group Inc	0.74%
Mariner Wealth Advisors LLC	0.73%
Geode Capital Management, LLC	0.64%
Renaissance Technologies Corp	0.56%

See all

About Neurometrix Inc

NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.

Organisation	Neurometrix Inc
E-voting on shares	Click here to vote

FAQs

What is Neurometrix Inc share price today?

Neurometrix Inc share price today is $4.58 as on May 2, 2025 at 1:25 am IST at the close of the market. Neurometrix Inc share today touched a day high of $4.58 and a low of $4.58.

What is the 52 week high and 52 week low for Neurometrix Inc share?

Neurometrix Inc share touched a 52 week high of $4.73 on November 1, 2024 and a 52 week low of $3.22 on November 5, 2024. Neurometrix Inc stock price today i.e. May 2, 2025 at 1:25 am IST is closed at $4.58,which is 3.17% down from its 52 week high and 42.24% up from its 52 week low.

How to invest in Neurometrix Inc Stock (NURO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neurometrix Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurometrix Inc Shares that will get you 0.3275 shares as per Neurometrix Inc share price of $4.58 per share as on May 2, 2025 at 1:25 am IST.

What is the minimum amount required to buy Neurometrix Inc Stock (NURO) from India?

Indian investors can start investing in Neurometrix Inc (NURO) shares with as little as ₹88.098 or $1 (as of September 11, 2025 at 3:09 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.98 in Neurometrix Inc stock (as per the Rupee-Dollar exchange rate as on September 11, 2025 at 3:09 am IST). Based on Neurometrix Inc share’s latest price of $4.58 as on May 2, 2025 at 1:25 am IST, you will get 2.1834 shares of Neurometrix Inc. Learn more about fractional shares .